RE:dm underpriced at .18?The information you are reporting is segment assets and liabilites. That's not debt. The company currently has two segments: Covid-19 Test Kits and AI &Technology. What you posted was the consolidated totals of the segmented assets and liabilities. In otherwords, the assets from those two segments total $38 196 360 and the liabilities (operating costs/activites) are $7 083 159. You do know those covid tests the company orders are not free. There are operating costs to make that money.
The AI & Technology assets have increase from $6 666 574 (March 31, 2021) to $20 676 473 (Aug 16, 2021). The segment liabilites for AI & Tech actually went down about $100 000 for that same time period.
If you want to check out debt, go to the section that is titled... wait for it... "Debt"
During the year ended December 31, 2020, the Company received requests from lenders demanding full payment of the loans with outstanding principal balance of $194,669, $66,749 and $57,380 which came with acquisition of Nexalogy and the Company fully repaid these loans during the six months ended June 30, 2021.
Current portion of long-term debt: 30 000
And if I recall correctly I believe I saw the net interest paid was about $1500
When I say "squeeky clean" balance sheet, I am simply repeating the words used by the CEO, but I would also say... he looks to be correct.